Approval · Notice of Compliance 538 · 2003
FUZEON: Notice of Compliance 538
Issued July 14, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 538
- Date
- July 14, 2003
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antiviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FUZEON | 02247725 | Cancelled Post Market |
Medicinal ingredients
- ENFUVIRTIDE 108 MG per VIAL